{"id":27099,"date":"2018-03-02T12:08:44","date_gmt":"2018-03-02T11:08:44","guid":{"rendered":"https:\/\/kymos.com\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/"},"modified":"2018-03-02T12:08:44","modified_gmt":"2018-03-02T11:08:44","slug":"kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen","status":"publish","type":"post","link":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/","title":{"rendered":"Kymos wurde als Referenzlabor f\u00fcr Biologika im Libanon zugelassen"},"content":{"rendered":"<p><span style=\"font-size: 14pt;\">Das <a href=\"https:\/\/www.moph.gov.lb\/en\" data-wpel-link=\"external\">libanesische Gesundheitsministerium<\/a> hat KYMOS als Referenzlabor f\u00fcr die Pr\u00fcfung biologischer Arzneimittel anerkannt. Dies ist eine wichtige Anerkennung der Bem\u00fchungen von KYMOS zur Entwicklung innovativer Analysemethoden f\u00fcr Biosimilars und biotechnologische Produkte. <\/span><\/p>\n<div class=\"blog-content\">\n<div class=\"field field-name-body field-type-text-with-summary field-label-hidden\">\n<div class=\"field-items\">\n<div class=\"field-item even\">\n<p><span style=\"font-size: 14pt;\">KYMOS verf\u00fcgt \u00fcber Erfahrung in der Methodenentwicklung, Validierung und Pr\u00fcfung verschiedener Biosimilars wie Infliximab, Trastuzumab, Pelgastrim oder Omalizumab; Polysaccharide wie Heparine; Immunglobuline; Insuline; und innovative Antik\u00f6rper-Wirkstoff-Konjugate.<\/span><\/p>\n<p> <span style=\"font-size: 14pt;\">Hier klicken: <a href=\"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/list_of_ref_lab_in_lebanon.pdf\" data-wpel-link=\"external\">Liste_der_Referenzlabore_im_Libanon.pdf<\/a><\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Das libanesische Gesundheitsministerium hat KYMOS als Referenzlabor f\u00fcr die Pr\u00fcfung  [&#8230;]<\/p>\n","protected":false},"author":6,"featured_media":27103,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[265,256],"tags":[],"class_list":["post-27099","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kymos-gruppe","category-nachricht"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kymos-Gruppe als Referenzlabor im Libanon<\/title>\n<meta name=\"description\" content=\"Erfahren Sie mehr \u00fcber die Zulassung von Kymos als Referenzlabor f\u00fcr Biologika durch das Gesundheitsministerium der Republik Libanon.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kymos-Gruppe als Referenzlabor im Libanon\" \/>\n<meta property=\"og:description\" content=\"Erfahren Sie mehr \u00fcber die Zulassung von Kymos als Referenzlabor f\u00fcr Biologika durch das Gesundheitsministerium der Republik Libanon.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/\" \/>\n<meta property=\"og:site_name\" content=\"Kymos\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-02T11:08:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kymos.com\/wp-content\/uploads\/2018\/03\/Banner_Lebanon-e1658232882595.png\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"221\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Joan Puig de Dou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:site\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joan Puig de Dou\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/\"},\"author\":{\"name\":\"Joan Puig de Dou\",\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"headline\":\"Kymos wurde als Referenzlabor f\u00fcr Biologika im Libanon zugelassen\",\"datePublished\":\"2018-03-02T11:08:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/\"},\"wordCount\":82,\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/Banner_Lebanon-e1658232882595.png\",\"articleSection\":[\"Kymos Group\",\"Nachricht\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/\",\"url\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/\",\"name\":\"Kymos-Gruppe als Referenzlabor im Libanon\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/Banner_Lebanon-e1658232882595.png\",\"datePublished\":\"2018-03-02T11:08:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"description\":\"Erfahren Sie mehr \u00fcber die Zulassung von Kymos als Referenzlabor f\u00fcr Biologika durch das Gesundheitsministerium der Republik Libanon.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/Banner_Lebanon-e1658232882595.png\",\"contentUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/Banner_Lebanon-e1658232882595.png\",\"width\":400,\"height\":221},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kymos.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kymos wurde als Referenzlabor f\u00fcr Biologika im Libanon zugelassen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/kymos.com\\\/de\\\/\",\"name\":\"Kymos Group\",\"description\":\"Kymos Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kymos.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kymos.com\\\/de\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\",\"name\":\"Joan Puig de Dou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"caption\":\"Joan Puig de Dou\"},\"description\":\"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.\",\"url\":\"https:\\\/\\\/kymos.com\\\/de\\\/news\\\/author\\\/joan-puig-de-dou\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kymos-Gruppe als Referenzlabor im Libanon","description":"Erfahren Sie mehr \u00fcber die Zulassung von Kymos als Referenzlabor f\u00fcr Biologika durch das Gesundheitsministerium der Republik Libanon.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/","og_locale":"de_DE","og_type":"article","og_title":"Kymos-Gruppe als Referenzlabor im Libanon","og_description":"Erfahren Sie mehr \u00fcber die Zulassung von Kymos als Referenzlabor f\u00fcr Biologika durch das Gesundheitsministerium der Republik Libanon.","og_url":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/","og_site_name":"Kymos","article_published_time":"2018-03-02T11:08:44+00:00","og_image":[{"width":400,"height":221,"url":"https:\/\/kymos.com\/wp-content\/uploads\/2018\/03\/Banner_Lebanon-e1658232882595.png","type":"image\/png"}],"author":"Joan Puig de Dou","twitter_card":"summary_large_image","twitter_creator":"@KymosGroup","twitter_site":"@KymosGroup","twitter_misc":{"Verfasst von":"Joan Puig de Dou"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/#article","isPartOf":{"@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/"},"author":{"name":"Joan Puig de Dou","@id":"https:\/\/kymos.com\/de\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"headline":"Kymos wurde als Referenzlabor f\u00fcr Biologika im Libanon zugelassen","datePublished":"2018-03-02T11:08:44+00:00","mainEntityOfPage":{"@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/"},"wordCount":82,"image":{"@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2018\/03\/Banner_Lebanon-e1658232882595.png","articleSection":["Kymos Group","Nachricht"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/","url":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/","name":"Kymos-Gruppe als Referenzlabor im Libanon","isPartOf":{"@id":"https:\/\/kymos.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/#primaryimage"},"image":{"@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2018\/03\/Banner_Lebanon-e1658232882595.png","datePublished":"2018-03-02T11:08:44+00:00","author":{"@id":"https:\/\/kymos.com\/de\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"description":"Erfahren Sie mehr \u00fcber die Zulassung von Kymos als Referenzlabor f\u00fcr Biologika durch das Gesundheitsministerium der Republik Libanon.","breadcrumb":{"@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/#primaryimage","url":"https:\/\/kymos.com\/wp-content\/uploads\/2018\/03\/Banner_Lebanon-e1658232882595.png","contentUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2018\/03\/Banner_Lebanon-e1658232882595.png","width":400,"height":221},{"@type":"BreadcrumbList","@id":"https:\/\/kymos.com\/de\/news\/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kymos.com\/de\/"},{"@type":"ListItem","position":2,"name":"Kymos wurde als Referenzlabor f\u00fcr Biologika im Libanon zugelassen"}]},{"@type":"WebSite","@id":"https:\/\/kymos.com\/de\/#website","url":"https:\/\/kymos.com\/de\/","name":"Kymos Group","description":"Kymos Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kymos.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/kymos.com\/de\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c","name":"Joan Puig de Dou","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","caption":"Joan Puig de Dou"},"description":"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.","url":"https:\/\/kymos.com\/de\/news\/author\/joan-puig-de-dou\/"}]}},"_links":{"self":[{"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/posts\/27099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/comments?post=27099"}],"version-history":[{"count":0,"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/posts\/27099\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/media\/27103"}],"wp:attachment":[{"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/media?parent=27099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/categories?post=27099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kymos.com\/de\/wp-json\/wp\/v2\/tags?post=27099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}